Big Move For PROG

PROG (PROG:NASDAQ) rocketted at $3.21, representing a gain of 28.9%. The stock appeared on our News Catalysts scanner on Thu, Jun 10, 2021 at 07:36 AM in the 'PRIVATE PLACEMENT' category. From Thu, May 27, 2021, the stock recorded 44.44% Up Days and 50.00% Green Days
About PROG (PROG:NASDAQ)
Progenity Inc is a biotechnology company. It is engaged in developing and commercializing molecular testing products. The company is translating innovation into precision medicine through diagnostic and therapeutic development platforms based on genomics, proteomics, and microbiomics. The firm generates its revenue from molecular laboratory tests, principally from the sale of Innatal, Preparent, and pathology molecular testing.
Top 10 Gainers:
- Novan, Inc. (NOVN:NASDAQ), 62.39%
- BAOS (BAOS:NASDAQ), 58.23%
- Urban One, Inc. (UONE:NASDAQ), 33.2%
- PROG (PROG:NASDAQ), 28.92%
- Iconix Brand Group, Inc. (ICON:NASDAQ), 27.76%
- EQOS (EQOS:NASDAQ), 25.81%
- Carver Bancorp, Inc. (CARV:NASDAQ), 24.22%
- Xinyuan Real Estate Co., Ltd. (XIN:NYSE), 23.55%
- Vaxart, Inc. (VXRT:NASDAQ), 21.9%
- The9 Limited (NCTY:NASDAQ), 20.69%